LONZA WALKERSVILLE, INC

Lonza Walkersville, Inc. specializes in the manufacturing of in-vitro diagnostic substances and the production of precision analytical laboratory instruments for life science research. The company delivers critical reagents, cell culture media, and electroporation systems—including the Nucleofector® platform—that enable advanced cell transfection, biomolecule delivery, and pathogenic antibody analysis in biomedical research settings. Their technical expertise lies in GMP-compliant production of specialized biological reagents, high-efficiency cell transfection technologies, and instrumentation for molecular and cellular analysis, serving as a trusted supplier for complex, reproducible workflows in immunology, virology, and regenerative medicine. Key differentiators include proprietary cell-specific media formulations, validated electroporation protocols, and end-to-end manufacturing control for sensitive biological materials used in preclinical and translational research. The contractor maintains a consistent, long-standing relationship with the Department of Health and Human Services, supplying mission-critical reagents and instruments to NIH institutes such as NIAMS and NHLBI for studies in autoimmune disease, critical care, and ribonucleoprotein biochemistry. Their work supports federal research initiatives requiring high-purity, traceable biological components and validated instrumentation, reinforcing a pattern of collaboration centered on precision life science tools. The primary industry focus is in in-vitro diagnostic substance manufacturing and analytical laboratory instrument production, positioning Lonza Walkersville as a niche provider for advanced cell biology and molecular diagnostics applications. They serve the biomedical research sector with specialized products that bridge laboratory innovation and scalable, compliant manufacturing. As a 2L entity headquartered in Walkersville, Maryland, Lonza Walkersville, Inc. operates as a mid-sized contractor with deep technical specialization in life sciences manufacturing. While no federal certifications are listed, their consistent delivery of GMP-aligned products to federal research agencies demonstrates regulatory alignment and quality systems maturity within the government life sciences supply chain.